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The lack of standardization of sedation scales in horses limits the reproducibility between
different studies. This prospective, randomized, blinded, horizontal and controlled trial
aimed to validate a scale for sedation in horses (EquiSed). Seven horses were treated
with intravenous detomidine in low/high doses alone (DL 2.5 µg/kg + 6.25 µg/kg/h;
DH 5 µg/kg +12.5 µg/kg/h) or associated with methadone (DLM and DHM, 0.2 mg/kg
+ 0.05 mg/kg/h) and with low (ACPL 0.02 mg/kg) or high (ACPH 0.09 mg/kg) doses
of acepromazine alone. Horses were filmed at (i) baseline (ii) peak, (iii) intermediate,
and (iv) end of sedation immediately before auditory, visual and pressure stimuli were
applied and postural instability evaluated for another study. Videos were randomized
and blindly evaluated by four evaluators in two phases with 1-month interval. Intra- and
interobserver reliability of the sum of EquiSed (Intraclass correlation coefficient) ranged
between 0.84–0.94 and 0.45–0.88, respectively. The criterion validity was endorsed by
the high Spearman correlation between the EquiSed and visual analog (0.77), numerical
rating (0.76), and simple descriptive scales (0.70), and average correlation with head
height above the ground (HHAG) (−0.52). The Friedman test confirmed the EquiSed
responsiveness over time. The principal component analysis showed that all items of the
scale had a load factor ≥ 0.50. The item-total Spearman correlation for all items ranged
from 0.3 to 0.5, and the internal consistency was good (Cronbach’s α = 0.73). The area
under the curve of EquiSed HHAG as a predictive diagnostic measure was 0.88. The
sensitivity of the EquiSed calculated according to the cut-off point (score 7 of the sum
of the EquiSed) determined by the receiver operating characteristic curve, was 96% and
specificity was 83%. EquiSed has good intra- and interobserver reliabilities and is valid
to evaluate tranquilization and sedation in horses.
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INTRODUCTION
The mortality related to general anesthesia in horses is high
and represents 0.9% for elective surgeries (1). A current
tendency exists to avoid general anesthesia when possible.
Therefore, certain diagnostic and surgical procedures commonly
use protocols based on constant rate infusions (CRIs) that
provide consistent sedation, analgesia with minimal ataxia in the
standing horse, thus ensuring the safety of the animal and those
involved (2–4).
Scales with different scoring methods and stimuli have
been proposed to determine the degree and quality of
sedation of pharmacological protocols (4). Head height
above the ground (HHAG) is an objective method expressed
on the percentage change from baseline, considered
as 100% (HHAG%). Reductions of the HHAG% by
50% or more represent a sufficiently sedated animal
(2, 3, 5). Subjective scoring methods, such as visual analog
(VAS) (6, 7), simple descriptive (SDS) (8, 9), numerical
(NRS), and composite numerical scales (composite NRS)
(10) are those that depend on the interpretation of
the evaluator.
Studies from the early 1990s evaluated the quality of sedation
using the composite NRS with mechanical, auditory, and visual
stimuli (11–13). In order to produce mechanical stimuli, the
use of pressure algometers (14) or tactile methods by touching
an object inside the ears or on the coronary band (11–13,
15) has been reported. Auditory stimuli ranged from clapping
behind (7, 11–13) or in front of the animal (15), sounds of
scraping a spoon in a can (5), shaking a plastic gallon container
filled with stones (14, 16) or the combination of auditory and
sensory stimuli of a grooming machine connected and played
in the lateral cervical region (17). Shaking a towel (7, 11–13) or
opening an umbrella in front of the horse (5, 18) were forms of
visual stimuli.
Postural instability and ataxia are subjective methods to
evaluate sedation with the animal standing still (11), in the first
case and by walking in a circular motion (5), or when getting over
small obstacles (14, 16) in the second case. For ataxia, the VAS
(2, 3), SDS (9, 19), and composite NRS have been described (7).
The use of reproducible and valid instruments is essential
to guarantee the reliability and accuracy of measurements
between different studies (20). Scale validation processes
include content validity, training of observers, frequency
distribution of scores, principal components analysis,
intra- (repeatability) and interobserver (reproducibility)
reliability, concurrent and construct validity (responsiveness),
item-total correlation, internal consistency, receiver
operating characteristic (ROC) curve, sensitivity, and
specificity (20–26).
This study hypothesis that the proposed scale, based on
stimuli and scales described in previous studies (2, 3, 7, 11–
18, 27–31), accurately and reliably measures tranquilization and
sedation in horses. Therefore, the current work aimed to develop
and validate a composite scale of sedation in horses (EquiSed)




The study was approved by the Ethics Committee on the Use
of Animals for research at the School of Veterinary Medicine
and Animal Science, São Paulo State University (UNESP),
Botucatu, SP, Brazil, under protocol 2017/0051. This prospective,
randomized, blinded, horizontal, and controlled study was
carried out on the experimental farm of the same institution,
to which the horses belonged. Their use was authorized by the
person in charge of the area of equine culture (JNPPF). Phase
I of the study was opportunistic with another study on equine
standing sedation/antinociception (18) comparing different CRI
protocols of detomidine alone or associated with methadone.
Phase II was added to investigate the addition of two different
doses of acepromazine under similar conditions of Phase I.
Animals
In both Phases I and II, the same three male geldings and four
female crossbred Quarter-horse and Appaloosa horses from the
same herd were used (18), with a mean ± SD (range) age of
10 ± 0.95 (9–11) years and weight of 402 ± 21 (372–450)
kg. Two weeks before the start of each phase of the study, all
the horses were classified as healthy based on normal physical
and laboratory examinations of blood count and biochemical
analysis (urea, alkaline phosphatase, alanine aminotransferase,
and gamma glutamyl transferase). The horses were kept on
pasture and fed with hay and commercial feed once a day. The
day before the study, the horse was separated and remained
in covered facilities, with water ad libitum and access to the
outside area. The solid fasting period was 2 h. Experimental
protocols were performed for each horse on fixed days and
periods (morning or afternoon) during the week to respect a
drug washout period of 7 days. After the study, the horses were
maintained at the farm of the institution and were used for riding
and reproduction, the latter only if females.
The sample size was calculated by using the differences
between the HHAG at baseline and maximal sedation, with a
mean of 42.7% and SD of 11.8%. This was based, on a previously
described pilot study (18), conducted with two horses undergoing
detomidine and methadone sedation protocols (DL 2.5 µg/kg +
6.25 µg/kg/h; DH 5 µg/kg +12.5 µg/kg/h; DLM and DHM, 0.2
mg/kg+ 0.05 mg/kg/h). The sample size was defined considering
a type I error probability (α) of 0.05 and power (1–β) of 0.80.
Based on this calculation, a sample size of four horses was
required. The sample size was also corroborated by previous
studies from the same group with the same animals (7) (https://
www.statstodo.com/SSizUnpairedDiff_Pgm.php).
Scale Development
The proposed scale was developed according to previously
described stimuli that evaluate sedation in horses (Table 1) (11–
13). For each item, specific response descriptions were assigned
to each score from 0 to 3 (Table 1), where 0 corresponds to no
sedation and 3 to maximum sedation. The sum of the items made
up the scale, where 0 represents the absence of sedation and 18
the maximum sedation.
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TABLE 1 | EquiSed to evaluate the quality and degree of tranquilization and sedation in horses.
Intensity of sedation
Head Height Above Ground (HHAG%) References
Height from chin to floor. The height of the head for each horse is measured at baseline and considered as
100%. Height during sedation is calculated as a percentage compared to height at baseline.
(2, 4, 7, 12–15, 18)
Stimuli performed Response to stimuli Scores References
Touch the ear (11, 12)
Touch inside the ears with
blunt-tipped material for 3 s
No response 3
Slight movement of the ear and/or head and/or neck 2
Intense movement of the ear and/or head and/or neck 1
Intense movement of the ear and head and/or neck and body movement 0
Press the coronary band of the thoracic limb (5, 11, 12)
Apply strong pressure for 3 s
with blunt-tipped material on the
coronary band of thoracic limb
No response 3
Moves the limb slowly without raising it 2
Raises the limb slowly 1
Raises the limb quickly before or when touched and/or moves the other limbs
and/or head and/or trunk
0
Press the coronary band of pelvic limb (5, 11, 12)
Apply strong pressure for 3 s
with blunt tipped material on the
coronary band of pelvic limb
No response 3
Moves the limb slowly without raising it 2
Raises the limb slowly 1
Raises the limb quickly before or when touched and/or moves the other limbs
and/or head and/or trunk
0
Postural instability (11–13, 15, 19, 31)
Observe the stationary animal
and then forcefully push it
laterally
Intense swaying, risk of falling down or falling down. Abducts (wide stance) the
thoracic and/or pelvic limbs, and/or one limb misaligned or crossed
3
Moderate swaying. Thoracic and/or pelvic limbs abducted (wide stance), and/or
one limb misaligned
2
No or slight swaying. One limb abducted (wide stance) 1
No swaying. Weight-bearing on all limbs, or resting one limb 0
Auditory (7, 11–13)
Response to loud hand clap
behind the animal
No response 3
Slow movement of the head and/or neck and/or ear(s) 2
Rapid movement of the head and/or neck and/or ear(s) 1
Rapid movement of the head and/or neck and/or ear(s) and body movement 0
Visual (5)
Response to opening an
umbrella in front of the animal
No response 3
Slight movement of the head and/or neck and/or ear(s) 2
Intense movement of the head and/or neck and/or ear(s) 1
Moves the head and/or neck and/or ear(s) and limb(s) 0
Maximum possible sum of the
EquiSed
18
EquiSed—Composite numerical scale of sedation in horses.
Data Collection
Phase I
The first Phase of the study was randomized (https://sorteador.
com.br) with the main evaluator (MGM) unaware of the
treatment received (18). The horses were weighed in a manual
weighing scale and taken to the six-square meters experimental
room for application of repellent, clipping the jugular areas,
antisepsis of the region, and insertion and fixation of a 14-gauge
catheter (G14 × 70mm) in the left jugular vein to administer
the drugs.
Before drug administration, the horses were placed to the
containment stocks inside the experimental room, where they
were fitted with the necessary equipment for the original study
(18). Two video cameras installed inside the experimental stall
were used to film the horse for viewing the animal as a whole, one
in an oblique craniocaudal position, and another in an oblique
caudocranial position.
After baseline data collection, one of the following intravenous
(i.v.) treatments (bolus + CRI for 120min) was administered:
DL—detomidine low dose alone (2.5 µg/kg followed by a CRI
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at 6.25 µg/kg/h), DH—detomidine high dose alone (5 µg/kg
followed by a CRI at 12.5 µg/kg/h), DLM—DL with methadone
(2.5µg/kg detomidine+ 0.2 mg/kg methadone followed by CRIs
of detomidine at 6.25 µg/kg/h and methadone at 0.05 mg/kg/h),
and DHM—DH with methadone (5 µg/kg bwt detomidine +
0.2 mg/kg of methadone followed by CRIs of detomidine at 12.5
µg/kg/h and methadone at 0.05 mg/kg/h). Once the drug(s) boli
were administered slowly by hand, CRIs were administered using
two calibrated syringe drivers, one for each drug. The CRIs were
administered for 2 h and the horses were kept in the stocks for
4 h due to the design of the pharmacokinetic phase (32) of the
principal study (18).
All data were collected at baseline (before drug
administration) and at 5, 15, 30, 60, 90, 120, 150, 180, 210,
and 240min after the start of the treatments. The HHAG was
measured in cm with a scale fixed to the wall ∼1.5 meters
away from the horse. The HHAG for each horse from chin to
floor was measured at baseline and considered as 100%. Height
during tranquilization/sedation was calculated as a percentage
compared to the height at baseline (2, 11). Afterwards, the
filming and application of EquiSed stimuli started in the same
order as the scale shown in Table 1. The EquiSed stimuli were
applied in situ by the evaluator unaware of the treatments.
Phase II
This phase was neither covert nor the treatments were
randomized at the in situ data collection, as it was included 11
months after Phase I. Horses were treated with i.v. acepromazine
boli at low (ACPL 0.02 mg/kg) and high doses (ACPH 0.09
mg/kg). The same methodology regarding the filming, stimuli
application and in situ data collection was used as in Phase I,
except that the horses were kept in the stocks for only 120 min.
Video Selection and Evaluations
To validate EquiSed, four representative moments of the possible
sedation intensities were defined: (i) baseline, (ii) peak sedation,
(iii) intermediate sedation, and (iv) end of sedation (return
to baseline).
Videos of Phase I at those representative moments were
selected based on results obtained in a previous study: (18,
32). (i) the baseline time was before drug(s) were administered
(T0), (ii) the peak of sedation was 120min (T120) after
the start of detomidine and immediately before the end of
CRIs (iii) intermediate sedation was at 30min after stopping
the CRI(s), and (iv) the final moment of sedation was at
120min after stopping the CRIs (T240—after starting the
drug administration).
The selection of Phase II videos was based on the in situ results
of the sedative effects of acepromazine. Themoments (i) baseline,
(ii) peak sedation at 60min, (iii) intermediate sedation at 90min,
and (iv) end of sedation at 120min after the administration of the
acepromazine boli were selected.
In total, 168 videos (7 horses × 6 treatments × 4
representative moments) were selected to be evaluated, each
lasting∼45 s.
Three Diplomates from the European College of Veterinary
Anesthesia and Analgesia (ECVAA) from different institutions
(MGM; SKR and SS), together with the responsible researcher
(ARO) evaluated the videos, independently. Evaluator 1 (E1—
ARO) had 7 years of experience in veterinary anaesthesiology
and sedation in horses, while evaluators 2, 3, and 4 (E2—
MGM, E3—SKR, and E4—SS) had an experience of 15, 17, and
18 years, respectively. Evaluator 2 was certified by ECVAA, in
2014 and E3 and E4 in 2009. The evaluators became familiar
with the EquiSed items through tutorial videos demonstrating
each score Supplementary Table 1. For training, the evaluators
assessed 10% of the total videos (16 videos, four from each
sedation moment) randomly, in two different periods, with
an interval of 1 month. Spearman’s correlation, intra- and
interobserver reliability values in this training phase were≥ 80%,
indicating that the evaluators were able to identify the intensity
of sedation similarly.
Once the training phase was completed, the main evaluations
took place after 2 months. The 168 videos were randomized
and made available on a Google Drive digital platform
(UNESP license—G Suit for Education) in two independent
folders (www.random.org), so that the evaluators could
allocate, unaware of the different sedation moments, the scores
corresponding to each video in two phases with intervals of 1
month. Before beginning the evaluations, the evaluators read the
instructions for the analysis and completion of the evaluation
worksheets. Instructions included: (1) how to evaluate the scale
and its descriptors to guarantee that the stimuli responses were
clear, and (2) how to complete the worksheets following the
evaluation of the videos. The evaluators were instructed to watch
the videos as many times as they deemed necessary to complete
the spreadsheets and to evaluate the videos for up to 1 h a day
so that fatigue would not interfere with the evaluation. The
spreadsheet was filled out in the order NRS, SDS, VAS for general
sedation, VAS for postural instability, and EquiSed, in the same
order in which the stimuli were applied. The HHAG values
used in this manuscript were only collected in situ by the main




The content validation of the EquiSed was performed in three
stages. First, the inclusion of stimuli described in previous studies
evaluating sedation in horses and their responses (Table 1).
Second, the critical analysis by the evaluators ARO, MGM, SKR,
and SS, regarding the interpretation of the EquiSed. Finally, the
analysis of the relevance, in which attribution of the importance
of each item was made as previously described in processes
for validating pain scales in other species (23, 25, 26). For
this last stage, three external evaluators (MOT, FAO, and CL),
all veterinary anaesthesiologists with more than 10 years of
experience in the field assigned the relevance of each scale item
from +1, for relevant, 0, for not being able to give an opinion,
and −1, for irrelevant. The mean relevance of each item was
calculated, and those with a value ≥ 0.5 remained in the EquiSed
scale (Table 1).
The relevance of all the items of EquiSed identified in
content validity indicated that the main videos scoring could
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be performed by the four evaluators, with these scoring data.
Therefore, all the following analysis were performed, except for
the HHAG%, that was not collected by video analysis.
All the following analyses were performed with data from all
evaluators, treatments, first and second evaluations, and grouped
moments, except where reported below.
Reliability
To evaluate intraobserver (repeatability; comparison of data from
the first and second evaluations of the videos) and interobserver
reliability (reproducibility; comparison of data from the first and
second evaluations of the videos between all the evaluators, also
called interobserver agreement matrix), we used the weighted
kappa coefficient (Kw) with a 95% confidence interval (CI) for
the NRS, SDS, and each item of the EquiSed. The disagreements
were weighted according to their distance to the square of perfect
agreement. The intraclass correlation coefficient (ICC) of the
agreement type with 95% CI was used to analyse the sum of the
EquiSed and the ICC of the consistency type with 95% CI to
analyse the VAS sedation and VAS postural instability. Reliability
for the weighted Kappa and ICC (CI) was considered to be
very good if 0.81–1.0; good if 0.61–0.80; moderate if 0.41–0.60;
reasonable if 0.21–0.40; and poor if <0.20 (33, 34).
Concurrent Criteria Validation
The concurrent criterion validity was based on Spearman’s
correlation between the sum of the EquiSed vs. the NRS, SDS, and
VAS scales (20, 26) and the HHAG%. To measure the correlation
between the EquiSed and HHAG%, treatments were grouped
into tranquilization (ACPL + ACPH), low dose detomidine
(DL + DLM), and high dose detomidine (DH + DHM), to
differentiate the correlation between acepromazine and the other
detomidine treatments.
Construct Validity (Responsiveness)
No data presented normal distribution according to Shapiro-
Wilk test. Therefore, the Friedman test was used for
responsiveness comparisons over time (baseline, peak sedation,
intermediate sedation, and end of sedation), and the Kruskal-
Wallis test for comparisons between treatments at each time,
with the Dunn’s post-test in both cases. For all variables, data
from all grouped evaluators were used, except for the HHAG%,
which used data from the study previously published with the
evaluations in situ (18).
Principal Component Analysis (PCA)
The PCA is a multiple association test that evaluates the
association of all items of the scale with each other (35).
This analysis was performed based on the correlation matrix.
The Kaiser criterion (36) was used to select dimensions with
eigenvalues > 1, variance > 20, and the items within dimensions
with load factor≥ 0.50 or ≤−0.50.
Item-Total Correlation
The item-total correlation was performed to identify the scale
homogeneity, through Spearman’s correlation between the score
attributed to each item vs. the sum of the EquiSed excluding the
item analyzed. Values were accepted between 0.3 and 0.7 (33).
Internal Consistency
The internal consistency of the scale was calculated using
Cronbach’s α coefficient (37), which determines how much the
items on the scale correlate with each other. Minimum acceptable
values were considered between 0.60 and 0.64, acceptable 0.65–
0.69, good 0.70–0.74, very good 0.75–0.80, and excellent above
0.80 (38).
Sensitivity and Specificity
To determine sensitivity and specificity, data were transformed
into dichotomous values for the presence (1, corresponding
to score 1, 2, or 3) or absence (0, corresponding to score 0)
of representative sedation scores at peak sedation times and
at baseline times, respectively. Specificity is generated by the
relationship between the total true negative results (horses not
sedated—score 0) in relation to the total number of evaluations at
baseline when the scores were not expected to indicate sedation.
Sensitivity was calculated by the ratio of true positives (horses
with scores 1, 2, or 3) in relation to the total number of
assessments at peak sedation. Both were interpreted as excellent,
when 95–100%, good, when 85–94.9%, moderate when 70–
84.9%, and non-sensitive or specific, when < 70% (24, 39). The
sensitivity and specificity of the total score of the scale was
performed based on the cut-off of the area under the receiver
operating characteristic (ROC) curve described below. Horses
showing scores > 7 at the peak of sedation were considered
sufficiently sedated and horses showing scores ≤ 7 at baseline
were considered non-sedated.
ROC Curve and Cut-Off Point for Sedation
Scores of horses treated with DH and DHM were used for
these calculations. The peak of sedation and baseline time points
were used to calculate sensitivity (true positives or truly sedated
horses) and specificity (true negatives or no sedated horses),
respectively. TheHHAG%≤50%was used as a predictive value to
consider truly sedated horses to build the ROC curve. The ROC
curve is the graphical representation of the relationship between
true positives (sensitivity) and false positives (1-specificity). Cut-
off point was defined by the Youden index (YI) and its diagnostic
uncertainty zone. The YI is the greatest coincident point of
sensitivity and specificity, determined by the ROC curve. The
gray zone (diagnostic uncertainty zone) indicates diagnostic
accuracy and is provided by calculating 95% CI by replicating
the original ROC curve 1,001 times by the bootstrap method and
by the interval between sensitivity and specificity. Gray zone was
considered the greatest interval of these two methods (33).
Frequency Distribution of Scores
The frequency of distribution of scores 0, 1, 2, and 3 of each item
at each time in the grouped treatments (ACPL + ACPH, DL +
DLM. and DH+DHM) was analyzed using descriptive statistics.
Statistical analysis was performed using R software in the
RStudio integrated development environment (RStudio Team-
−2016) and Microsoft Office R© (Excel−2019).
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RESULTS
The EquiSed showed intra- and interobserver reliability,
content, criterion, and construct validity and adequate item-total
correlation and internal consistency.
Training
In the training stage, the evaluators presented excellent
interobserver reliability (82–93%) and intraobserver reliability
(88, 82, 91, and 85% for E1–E4, respectively).
Content Validity
The characteristics described based on previous studies, and the
semantic clarity of the items’ descriptions were approved by the
evaluators of the study (Table 1).
All items on the scale had a sum >0.5 for the mean degree
of relevance for the three external veterinary anaesthesiologists.
Thus, there were no changes in the content of the scale.
Intraobserver Reliability (Repeatability)
Results of intraobserver reliability are presented in Table 2. The
repeatability of the EquiSed varied from good to very good for
thoracic limbs and visual items (CI 0.69–0.95). The other items
were reasonable to very good (CI 0.37–0.93). The repeatability
of the sum of the EquiSed was very good (CI 0.84–0.94), the
NRS varied from moderate to very good (CI 0.67–0.93), the VAS
sedation from moderate to very good (CI 0.62–0.92), the VAS
postural instability from moderate to very good (CI 0.54–0.87),
and the SDS from moderate to very good (CI 0.47–0.83).
Interobserver Agreement Matrix
(Reproducibility)
Results of interobserver reliability are presented in Table 3.
The individual items showed poor to very good interobserver
reliability (CI 0.18–0.91). The sum of EquiSed showed moderate
to very good interobserver reliability (CI 0.45–0.88). The
reliability of the NRS and VAS sedation ranged frommoderate to
very good (CI 0.50–0.85). The SDS andVAS of postural instability
showed reasonable to good reliability (CI 0.20–0.66), respectively.
Concurrent Criterion Validity
The correlations between the sum of the EquiSed and all
other scales were high when all the treatments were analyzed
combined, except for the HHAG%, which presented a medium
correlation, just as in low (DL + DLM) and high (DH + DHM)
detomidine, and a low correlation for tranquilization (ACPL +
ACPH) (Table 4).
Construct Validity (Responsiveness)
Results of responsiveness are presented in Table 5. The postural
instability and auditory stimuli were responsive, as shown by the
difference between the baseline and the peak of sedation value,
with all treatments. The touch in the ears and the visual stimuli
showed responsiveness for all detomidine treatments, but not
for the two doses of acepromazine. The pressure stimuli on the
thoracic and pelvic limbs were responsive for the high doses
of detomidine (DH + DHM) only. When all treatments were
grouped, all items showed responsiveness.
All scales were responsive in all treatments, demonstrating
higher values at peak sedation or intermediate sedation
compared to baseline, except for the HHAG% which showed
lower values at peak sedation or intermediate sedation compared
to baseline (Table 5, Figure 1). When all treatments were
grouped, scores on all scales were higher at the peak sedation
and intermediate sedation in relation to the baseline and final
moment of sedation. All the scales were able to differentiate
the peak sedation from intermediate sedation, except for
the HHAG%.
For horses receiving acepromazine, the scores of all scales
except for HHAG% were higher at the final moment compared
to baseline (Table 5, Figure 1).
Differences between treatments at peak of sedation were
detected by all scales, except HHAG%. Sedation scores were
highest with DH, followed by DL and ACP. The addition of
methadone did not increase sedation.
Principal Component Analysis (PCA)
The analysis of multiple associations by principal components
defined the items with load factor of ≥ 50% (Table 6), acceptable
according to the Kaiser criteria (36).
All items on the scale have the same vectorial direction
to identify sedated animals (Figure 2). The histogram of each
eigenvalue is represented on Figure 3.
Item-Total Correlation and Internal
Consistency
The item-total correlation ranged from 0.31 to 0.54, so all items
(0.3–0.7) were accepted (Table 7) (33). The internal consistency
was good for the total score of the scale and acceptable or good
when excluding each item.
Sensitivity and Specificity
When considering all treatments grouped, all items, except the
stimuli on the limbs demonstrated sensitivity. On the other
hand, only these stimuli demonstrated specificity (Table 7). The
sensitivity and specificity of the sum of the scale were 0.96 (CI
0.93–0.99) and 0.83 (CI 0.76–0.89), respectively.
ROC Curve and Cut-Off Point for Sedation
The area under the curve was 0.88 and therefore considered to be
a moderate discriminatory capacity (Figure 4) (41). The Youden
index was > 7 for all pooled evaluators. The range between
sensitivity and specificity > 0.90 was between 6.9 and 10. The
resampling bootstrap CI was 6.5–8.5. Based on the resampling
result, the diagnostic uncertainty zone ranged from 7 to 10, which
indicates that scores < 7 are horses that are not sufficiently
sedated while scores > 10 are those that are truly sedated. The
YI were ≥ 5 for NRS, ≥ 1 for SDS and ≥ 43 for VAS.
Frequency Distribution of Scores
The frequencies of occurrence of the percentage scores for each
item of the EquiSed in horses subjected to high detomidine (DH
+DHM), low detomidine (DL+DLM), or acepromazine (ACPL
+ ACPH) are shown in Figure 5.
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TABLE 2 | Intraobserver reliability of the NRS, SDS, EquiSed items, sum of EquiSed, VAS sedation, and VAS postural instability scores in horses treated with
acepromazine or detomidine alone or associated with methadone.
EquiSed items E1 E2 E3 E4
kw CI kw CI kw CI kw CI
NRS 0.80 0.73–0.85 0.89 0.85–0.93 0.90 0.85–0.93 0.75 0.67–0.82
SDS 0.73 0.64–0.82 0.69 0.57–0.78 0.75 0.65–0.83 0.55 0.47–0.64
Ears 0.67 0.57–0.76 0.78 0.68–0.86 0.77 0.70–0.82 0.73 0.65–0.81
Thoracic limb 0.91 0.82–0.95 0.89 0.75–0.95 0.90 0.81–0.95 0.92 0.87–0.95
Pelvic limb 0.81 0.59–0.91 0.83 0.70–0.92 0.86 0.75–0.93 0.80 0.71–0.89
Postural instability 0.69 0.57–0.78 0.58 0.46–0.68 0.78 0.71–0.84 0.53 0.39–0.64
Auditory 0.62 0.51–0.71 0.62 0.46–0.73 0.59 0.47–0.68 0.58 0.37–0.70
Visual 0.82 0.76–0.87 0.85 0.78–0.90 0.84 0.77–0.90 0.76 0.69–0.87
ICC (agreement)
ICC CI ICC CI ICC CI ICC CI
Sum of the EquiSed 0.89 0.84–0.92 0.91 0.87–0.94 0.91 0.88–0.94 0.89 0.84–0.92
ICC (consistency)
ICC CI ICC CI ICC CI ICC CI
VAS sedation 0.76 0.69–0.82 0.89 0.85–0.92 0.89 0.86–0.92 0.71 0.62–0.78
VAS postural instability 0.70 0.62–0.77 0.64 0.54–0.72 0.83 0.78–0.87 0.56 0.45–0.66
EquiSed—Numerical composite sedation scale in horses, NRS—Numerical rating scale, SDS—Simple descriptive scale, VAS—Visual analog scale. E1, Evaluator 1; E2, Evaluator 2;
E3, Evaluator 3; E4, Evaluator 4. Interpretation of weighted Kappa (kw ) and ICC (intraclass correlation coefficient)—very good if 0.81–1.0; good if 0.61–0.80; moderate if 0.41–0.60;
reasonable if 0.21–0.40; and poor if < 0.20. CI (confidence interval) (33, 34). Bold values represent the Kw and ICC of intraobserver reliability.
There was a low frequency of 0 scores for the touch
the ears, auditory, and visual stimuli. The frequency of
scores of 3 predominated at peak sedation for the auditory
stimulus in horses receiving low and high detomidine and
for the visual stimulus in horses subjected to high dose
detomidine. Although the frequency of scores 3 predominated
for pressure on the thoracic limb during peak sedation,
there was still a high frequency of scores 0 during high
detomidine sedation.
In the stimulus pressure on the pelvic limb, the score 0
predominated at all times. However, for this item, the frequency
of higher scores increased proportionally with the intensity
of sedation. Postural instability was the item that presented
the most consistent results according to the moment and
treatment protocols.
DISCUSSION
The results of this study show that EquiSed differentiated low and
deep sedation and is an applicable scale for experimental and
clinical studies in horses. Equised identified different levels of
sedation according to the validation and reliability criteria used
in pain and sedation scales in different animal species and in
humans (20–22, 24, 25, 42, 43).
The validation of this scale was based on the observation
of the behavioral response of horses first while conscious and
without any drugs given, and also after tranquilization/sedation.
With the aim to standardize the methodology and guarantee
the reproducibility of future studies, the EquiSed compiled the
different methods for evaluation of the behavioral responses to
the stimuli described since the 1990s (5, 7, 11–13, 15, 19, 31).
Acepromazine and detomidine alone or associated with
opioids produce tranquilization and sedation and different
degrees of hypo-reactivity to environmental stimuli (7, 18, 30).
To validate the EquiSed and to ensure reliability for clinical and
experimental use, we selected experienced evaluators familiarized
with the use of widely used drugs in equine medicine (2–5, 7, 27,
44, 45). The methodology used for validation and evaluation of
intra and interobserver reliability was similar to that described to
validate pain scales in animals (20–26), which comprises blinded
evaluators and randomized videos to minimize interpretation
bias (46). Usually, in other metrics, especially in the area of
pain, inexperienced evaluators are included in the validation
process, for greater scope in applying the scale (47). Therefore,
further validation will be needed when this instrument is used by
inexperienced evaluators.
Before the video analysis, content validity was performed.
The stimuli already described and reported in the literature
were improved and detailed, and its relevance and clarity of
the description of all items (35, 48) was assessed by three
other experienced researchers in accordance with the process
of validation of other animal scales (20–26, 33). Content
validity evaluates the representativeness of the items (49) and
is correlated with the repeatability and reproducibility of the
scale (50).
The four evaluators recruited for our study were experienced
veterinary anaesthesiologists. However, general experience does
not guarantee good reliability for a specific attribute (51). Reliable
scales are essential when interpreting their results (52). Factors
that affect reliability include lack of practice/experience, the
fatigue of the evaluator, and the inadequate description of the
items of a scale (50). Previous studies stated that familiarization
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TABLE 3 | Interobserver agreement matrix of the sedation scores of the NRS, SDS, EquiSed items, sum of EquiSed, VAS sedation, and VAS postural instability in horses
treated with acepromazine or detomidine alone or associated with methadone.
Evaluator E1 E2 E3
kw CI kw CI kw CI
NRS
E2 0.72 0.66–0.77
E3 0.75 0.70–0.80 0.78 0.73–0.82
E4 0.67 0.60–0.72 0.79 0.74–0.84 0.81 0.76–0.85
SDS
E2 0.41 0.34–0.47
E3 0.34 0.28–0.40 0.43 0.35–0.50
E4 0.43 0.36–0.50 0.60 0.52–0.66 0.59 0.51–0.64
Touch the ears
E2 0.66 0.59–0.73
E3 0.63 0.56–0.70 0.61 0.54–0.67
E4 0.54 0.47–0.61 0.58 0.51–0.65 0.69 0.62–0.74
Pressure on the thoracic limb
E2 0.92 0.87–0.94
E3 0.92 0.97–0.94 0.92 0.86–0.95
E4 0.90 0.86–0.93 0.92 0.87–0.95 0.91 0.86–0.94
Pressure on the pelvic limb
E2 0.77 0.65–0.85
E3 0.82 0.73–0.89 0.85 0.78–0.91
E4 0.68 0.56–0.76 0.75 0.66–0.83 0.78 0.71–0.85
Postural instability
E2 0.47 0.39–0.54
E3 0.54 0.47–0.61 0.50 0.40–0.57
E4 0.40 0.31–0.49 0.43 0.33–0.51 0.43 0.34–0.51
Auditory
E2 0.47 0.40–0.54
E3 0.52 0.44–0.59 0.58 0.50–0.66
E4 0.31 0.26–0.38 0.26 0.18–0.33 0.37 0.29–0.44
Visual
E2 0.74 0.68–0.78
E3 0.64 0.57–0.70 0.72 0.66–0.77
E4 0.38 0.33–0.44 0.46 0.41–0.51 0.55 0.49–0.61
ICC CI ICC CI ICC CI
EquiSed
E2 0.81 0.77–0.85
E3 0.78 0.74–0.82 0.86 0.83–0.88
E4 0.53 0.45–0.61 0.72 0.66–0.77 0.78 0.73–0.82
VAS sedation
E2 0.65 0.58–0.71
E3 0.75 0.70–0.80 0.74 0.69–0.79
E4 0.58 0.50–0.64 0.78 0.74–0.82 0.75 0.70–0.79
VAS postural instability
E2 0.44 0.35–0.52
E3 0.59 0.52–0.66 0.30 0.20–0.39
E4 0.42 0.33–0.50 0.44 0.35–0.52 0.32 0.22–0.41
EquiSed—Numerical composite sedation scale in horses, NRS—Numerical rating scale, SDS—Simple descriptive scale, VAS—Visual analog scale. E1, Evaluator 1; E2, Evaluator 2;
E3, Evaluator 3; E4, Evaluator 4. Interpretation of weighted Kappa (kw ) and ICC—very good if 0.81–1.0; good if 0.61–0.80; moderate if 0.41–0.60; reasonable if 0.21–0.40; and poor if
<0.20. CI (confidence interval) (33, 34). Bold values represent the Kw and ICC of intraobserver reliability.
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TABLE 4 | Correlation between the EquiSed with the NRS, SDS, and VAS sedation registered by analyzing the videos and with the HHAG% recorded in situ in horses
treated with acepromazine or detomidine alone or associated with methadone.
Scales/EquiSed Treatments Grouped moments
NRS Tranquilization (ACPL + ACPH) 0.65 CI (0.63–0.73)
Low detomidine (DL+ DLM) 0.69 CI (0.68–0.76)
High detomidine (DH + DHM) 0.84 CI (0.82–0.88)
All treatments 0.77 CI (0.74–0.79)
SDS Tranquilization (ACPL + ACPH) 0.57 CI (0.51–0.64)
Low detomidine (DL+ DLM) 0.67 CI (0.63–0.74)
High detomidine (DH + DHM) 0.78 CI (0.77–0.83)
All treatments 0.70 CI (0.67–0.73)
VAS sedation Tranquilization (ACPL + ACPH) 0.64 CI (0.61–0.71)
Low detomidine (DL+ DLM) 0.68 CI (0.66–0.77)
High detomidine (DH + DHM) 0.84 CI (0.83–0.88)
All treatments 0.76 CI (0.73–0.78)
HHAG% Tranquilization (ACPL + ACPH) −0.14 CI (−0.07–0.43)
Low detomidine (DL+ DLM) −0.40 CI (−0.28 to −0.68)
High detomidine (DH + DHM) −0.69 CI (−0.66 to −0.85)
All treatments −0.52 CI (−0.65 to −0.44)
EquiSed—Numerical composite sedation scale in horses, NRS—Numerical rating scale, SDS—Simple descriptive scale, VAS sedation—Visual analog scale of sedation. HHAG%, Head
height above the ground %. Interpretation of Spearman’s correlation−0–0.35–low correlation; 0.35–0.7—medium correlation; 0.7–1.0—high correlation. Bold values correlation> 70
(20, 33, 40).
with the scale guarantees ability (53, 54), therefore previous
training should have ensured good intra- and interobserver
reliability in the current study. To reduce fatigue, the video
analysis had clear instructions to the evaluators to watch the
videos for up to a maximum of 1 h a day.
Despite the previously described cautions, intra- and
interobserver reliability for the items auditory and visual stimuli
and postural instability presented worse results compared to
the other stimulli. These low-reliability values raise the question
if these items are reproducible when evaluated in isolation
in sedation studies in horses. However, apparently, even the
inclusion of these stimuli together with others guaranteed the
reliability of the sum of the EquiSed, which presented the highest
repeatability of all the scales (NRS, SDS, and VAS); EquiSed had
a very good intraobserver reliability and moderate to very good
interobserver reliability.
The SDS in this study presented reliabilities ranging from
reasonable to very good. These results showed that the
reproducibility of the SDS can be compromised when comparing
results from different studies. This is mainly due to the fact
that unidimensional scales can be subjectively interpreted by the
evaluator (2, 3, 5). Similar inconsistent reproducibility results
were observed for the SDS when evaluating pain in other species
such as dogs (55).
The concurrent criterion validity measures how much the
new instrument correlates with a gold standard tool (33, 47).
Unfortunately, a validated and therefore gold standard method
for sedation assessment in horses has not been available in
the literature yet. This did not allow us to have a reliable
determination of the accuracy and efficacy of EquiSed. The
alternative approach used in the current study for the concurrent
criterion validity test was to correlate the EquiSed against
unidimensional scales (NRS, VAS, SDS) and HHAG%. This was
a similar approach used in previous studies which developed
and validated pain scales in other species (20, 26, 56, 57). In
addition, HHAG%was incorporated in the current study because
this is a well-recognized method for assessing the degree of
sedation in horses (2, 5, 7, 11, 12). According to this criteria,
EquiSed presented a high correlation with these other scales and
these correlations improved as the intensity of sedation increased
(acepromazine < low detomidine < high detomidine) (58).
Construct validity evaluates responsiveness. Possible drugs,
doses, and associations used in clinical and experimental
settings were included to evaluate their effects on the
score values. EquiSed identified differences between the
moments before and after sedation/tranquilization and
differences between treatments and doses. EquiSed scores
were proportional to tranquilization/sedation degree, i.e., the
highest scores were attributed to the peak and/or intermediate
tranquilization/sedation, and the lowest scores were attributed to
the baseline. However, the tranquilizing effect of acepromazine
overtime remained for up to 120min (end of sedation)
(10, 59). At this time, the effect of acepromazine was even
greater than in treatments with detomidine. For this reason,
studies using acepromazine should consider its prolonged
tranquilizing effect.
The authors recognize that some parameters are not
specific for sedation and might be influenced by, for instance,
antinociception. But also the opposite, when one investigates
the effects of analgesic drugs, may be a confounding factor. In
the previously published study performed simultaneously (18),
nociceptive threshold was greater and longer in animals treated
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TABLE 5 | Responsiveness during and between treatments of the EquiSed, NRS, SDS, VAS sedation, and HHAG% in horses treated with acepromazine or detomidine
alone or associated with methadone.
Moments
Scales Baseline Peak of sedation Intermediate sedation End of sedation
Items Median Amplitude Median Amplitude Median Amplitude Median Amplitude
NRS ACPL 2cAB 1–5 2bcC 1–6 3aB 1–6 2bB 1–5
ACPH 1bB 0–6 4aB 1–7 4aB 1–7 4aA 1–7
DL 2bcA 1–7 5aB 2–9 3bB 1–8 2cBC 1–5
DLM 1cB 0–6 5aB 1–8 3bB 1–7 2cC 1–4
DH 2cAB 0–6 7aA 5–9 4bA 2–8 2cC 1–5
DHM 2cAB 1–5 8aA 4–10 6bA 2–8 2cBC 1–5
All 2d 0–7 5a 1–10 4b 1–8 2c 1–7
SDS ACPL 1b 0–2 1abC 0–2 1aC 0–2 1abAB 0–2
ACPH 0b 0–2 1aB 0–2 1aBC 0–2 1aA 0–2
DL 1bc 0–2 2aB 0–3 1bC 0–2 1cB 0–2
DLM 0c 0–2 2aB 0–3 1bC 0–2 1cB 0–1
DH 1c 0–2 2aA 1–3 1bAB 0–2 1cB 0–2
DHM 1b 0–2 2aA 1–3 2aA 0–3 1bB 0–2
All 1c 0–2 2a 0–3 1b 0–3 1c 0–2
Ears ACPL 1 0–2 1C 0–2 1B 0–3 1 0–2
ACPH 1 0–3 1B 0–3 1B 0–3 1 0–3
DL 1b 0–2 1aB 1–3 1abB 0–2 1b 0–3
DLM 1b 0–3 1aB 0–3 1abB 0–3 1b 0–3
DH 1b 0–3 2aA 0–3 1bAB 0–2 1b 0–3
DHM 1b 0–2 2aA 1–3 2aA 0–3 1b 0–2
All 1c 0–3 2a 0–3 1b 0–3 1c 0–3
Thoracic ACPL 0 0–3 0C 0–3 0AB 0–3 0A 0–3
limb ACPH 0 0–3 0ABC 0–3 0A 0–3 0A 0–3
DL 0 0–3 0C 0–3 0AB 0–3 0AB 0–2
DLM 0 0–2 0BC 0–3 0AB 0–1 0AB 0–2
DH 0b 0–2 3aAB 0–3 0bB 0–1 0bB 0–1
DHM 0b 0–1 2aA 0–3 0bAB 0–2 0bB 0–1
All 0b 0–3 0a 0–3 0b 0–3 0b 0–3
Pelvic ACPL 0 0–1 0C 0–2 0AB 0–2 0AB 0–2
limb ACPH 0 0–2 0C 0–1 0B 0–2 0AB 0–2
DL 0 0–1 0C 0–1 0B 0–1 0B 0–0
DLM 0b 0–1 0aBC 0–1 0abB 0–1 0bB 0–1
DH 0b 0–1 1aAB 0–2 0bAB 0–1 0bB 0–1
DHM 0b 0–1 2aA 0–3 0bA 0–2 0bA 0–1
All 0b 0–2 0a 0–3 0b 0–2 0b 0–2
Postural ACPL 0bC 0–1 1aC 0–2 1aABC 0–2 1aAB 0–2
instability ACPH 0bBC 0–1 1aBC 0–2 1aBC 0–2 1aA 0–2
DL 1abA 0–1 1aB 0–2 1abBC 0–1 0bBC 0–2
DLM 0bABC 0–2 1aB 0–2 1bB 0–1 0bC 0–1
DH 1cAB 0–1 2aA 0–2 1bAC 0–2 0cBC 0–1
DHM 0cABC 0–2 2aA 0–3 1bA 0–2 0cBC 0–2
All 0c 0–2 1a 0–3 1b 0–2 0c 0–2
Auditory ACPL 2b 0–3 2aC 1–3 2aB 1–3 2abAB 1–3
ACPH 2b 1–3 2aBC 1–3 2aB 0–3 2aAB 1–3
DL 2b 0–3 3aA 2–3 2abB 1–3 2bB 1–3
DLM 2b 0–3 3aA 1–3 2aB 1–3 2bAB 1–3
DH 2b 1–3 3aA 1–3 3aA 1–3 2bAB 0–3
(Continued)
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TABLE 5 | Continued
Moments
Scales Baseline Peak of sedation Intermediate sedation End of sedation
Items Median Amplitude Median Amplitude Median Amplitude Median Amplitude
DHM 2b 0–3 3aAB 1–3 3aA 2–3 2bA 1–3
All 2c 0–3 3a 1–3 2a 0–3 2b 0–3
Visual ACPL 1 0–3 1C 1–3 1C 1–3 2AB 0–3
ACPH 1b 0–3 2aBC 1–3 2aBC 0–3 2aA 0–3
DL 1c 0–2 2aB 0–3 2abBC 0–3 1bcB 0–3
DLM 1b 0–3 2aB 0–3 2aAB 0–3 1bB 0–3
DH 2b 1–3 3aA 1–3 3aAB 1–3 2bAB 0–3
DHM 2b 0–3 3aA 2–3 3aA 1–3 1bB 0–2
All 1c 0–3 2a 0–3 2a 0–3 2b 0–3
EquiSed ACPL 5b 1–10 6aC 3–12 6aB 3–14 6aAB 2–12
ACPH 4,5b 1–15 7aB 3–15 7aB 2–13 7aA 3–14
DL 5,5c 2–12 7aB 5–14 6bB 2–12 5cBC 2–9
DLM 4c 1–10 7aB 3–14 7bB 1–11 4,5cC 1–8
DH 6c 2–10 11aA 7–16 8bAB 3–11 5cBC 2–9
DHM 5c 2–11 12aA 9–16 8,5bA 5–15 5cBC 2–10
All 5d 1–15 9a 3–16 7b 1–15 5c 1–14
VAS sedation ACPL 7c 0–50 14bcC 0–59 24aB 0–62 19bAB 0–51
ACPH 6b 0–60 36aB 0–64 31aB 0–67 28aA 0–77
DL 15bc 0–61 47aB 2–83 22bB 0–73 10cBC 0–56
DLM 6c 0–52 48aB 0–82 22bB 0–86 9cC 0–36
DH 6c 0–52 70aA 44–99 40bA 14–81 7cC 0–46
DHM 7c 0–47 76aA 31–99 55bA 4–80 11cBC 0–54
All 7d 0–61 49a 0–99 32b 0–86 14c 0–77
VAS postural instability ACPL 0cB 0–16 3bcD 0–31 10aBC 0–53 5abAB 0–30
ACPH 0bB 0–22 12aC 0–65 10aBC 0–47 10aA 0–66
DL 7bA 0–30 12aC 0–74 7bC 0–41 2bB 0–43
DLM 1bcAB 0–30 17aBC 0–62 6bC 0–39 0cB 0–25
DH 0cAB 0–24 28aA 0–85 15bAB 0–77 3cB 0–22
DHM 1cAB 0–37 41aAB 7–92 15bA 0–69 2cAB 0–51
All 0.5c 0–37 15a 0–92 10b 0–77 3c 0–66
Height Head Above the
Ground%*
ACPL 100a 100–100 89abA 27–100 84bAB 81–90 95ab 71–103
ACPH 100a 100–100 66bAB 53–91 82abAB 50–102 92ab 68–105
DL 100a 100–100 53bAB 22–71 93abA 44–105 103a 83–110
DLM 100a 100–100 64bAB 29–89 85abAB 47–95 100a 96–107
DH 100a 100–100 27bB 18–47 60abB 27–80 100a 86–105
DHM 100a 100–100 29bB 14–74 68abAB 26–95 102a 84–147
All 100a 100–100 53b 14–100 82b 26–105 100a 68–147
EquiSed—Numerical composite sedation scale in horses, NRS—Numerical rating scale, SDS—Simple descriptive scale, VAS—Visual analog scale; ACPL + ACPH (acepromazine in
low and high doses); DL + DLM (detomidine in low and high doses); DH + DHM (detomidine in low and high doses); *data obtained from a previously published article (18). Different
lower-case letters represent statistical differences over time (p < 0.05) (a> b> c). Different capital letters represent statistical differences between treatments (p < 0.05) (A>B>C).
with the high dose of detomidine and methadone, compared to
detomidine alone. Otherwise, the sedation data of the current
study showed that the inclusion of methadone did not increase
either the total sedation scores or the scores of any separated
item. In both previous studies (7, 18), methadone increased
detomidine-induced antinociception without increasing
sedation. However, even so, it is difficult to differentiate for pelvic
and thoracic limb stimuli, sedation from antinociception in
horses treated with alpha-2 agonists. None of the sedation scales
differentiated the effect of including methadone in each dose
of detomidine.
EquiSed detected differences between the high degree
of sedation vs. both low degree of sedation and vs. low
degree of tranquilization but did not differentiate the high
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FIGURE 1 | EquiSed scores before and after (A) tranquilization (ACPL + ACPH), (B) low detomidine (DL + DLM) and (C) high detomidine (DH + DHM). ACPL +
ACPH—acepromazine in low and high doses; DL + DLM—detomidine in low dose and associated with methadone; DH + DHM—detomidine in high dose and
associated with methadone. Baseline—baseline moment; Peak of sedation—peak of sedation; Intermediate—intermediate sedation; and end of sedation. Different
symbols indicate significant differences between scores (p < 0.05). † > ‡> §.
TABLE 6 | Load values, eigenvalues, and variance of EquiSed items by the principal component analysis.
EquiSed Items Load factors in Dimension 1 Load factors in Dimension 2
Touch the ears 0.67 0.07
Pressure on the thoracic limb 0.71 0.50
Pressure on the pelvic limb 0.72 0.36
Postural Instability 0.68 −0.17
Auditory stimulus 0.48 –0.76
Visual stimulus 0.68 −0.27
Eigenvalue 2.62 1.07
Variance 43.64 17.84
EquiSed—Numerical composite sedation scale in horses. Eigenvalues> 1, variance > 20 and load factor ≥ 0.50 or ≤ −0.50 are approved (36). Load factors represent the correlation
of items with the scale and how much each item contributes to each factor. Bold values represent load factor ≥ 0.50 or ≤ −0.50.
degree of tranquillisation from a low degree of sedation. At
the peak of sedation, the total score and the items postural
instability and auditory and visual stimulus identified low
tranquilization with acepromazine vs. the other groups.
Therefore, the scores apparently increased proportionally
to the degree of central nervous system (CNS) depression.
All items significantly increased the EquiSed score in horses
treated with high detomidine, in both peak sedation and/or
intermediate sedation. There was very similar responsiveness
among the unidimensional scales and EquiSed. As expected,
HHAG%, the most used parameter for sedation in horses,
likewise the other scales, decreased as detomidine dose
increased. If we consider the current interpretation of
HHAG% (2), only horses treated with the high detomidine
dose could be regarded as sufficiently sedated (≤ 50%) in
the current study, the value used to define the Youden
index (i.e., horses with EquiSed scores > 7 are considered
sufficiently sedated).
The PCA identifies how variables are grouped into factors
or dimensions (60) to determine the extent of the scale (61).
Based on this analysis, all stimuli were approved on the scale
(62, 63). The vector analysis showed that all stimuli were
directed to the right side of the graph where moments of
greater sedation were located, confirming that all the items can
identify sedation.
The item-total correlation confirmed the homogeneity and
importance of each item on the EquiSed (64), demonstrating that
all items contribute to the final score. The internal consistency
which correlates the different items on the scale was acceptable
for all the items, suggesting that they are representative for
evaluating sedation in horses (33).
Sensitivity and specificity evaluate the accuracy in identifying
sedated and non-sedated animals, respectively. The α-2
adrenergic agonists reduce the response to different stimuli (7).
However, the low sensitivity to tactile stimuli in the limbs in
this study may be related to the learning effect already described
(5), despite the efforts to minimize this effect by alternating
the limb stimulation. Other possible explanations are that the
α-2 adrenergic agonist-reduction of tactile stimuli response is
dose-dependent. High (20 µg/kg of detomidine) but not low
doses reduce the response to tactile stimuli on the limbs (13).
Still, some authors sustained that even horses deeply sedated
with α-2 adrenergic agonists alone can react to touch (65, 66).
The most evident ataxia occurs only from doses> 5µg/kg (8). In
this study, maximum ataxia was not found, which corroborates
the low sensitivity to tactile stimuli in the limbs.
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FIGURE 2 | Biplot of the principal component analysis of the EquiSed. Confidence ellipses were built according to the moments before and after sedation. Baseline
(green); peak of sedation (red); intermediate sedation (purple); end of sedation (blue). The ellipses on the left represent the absence or end of sedation and on the right
represent the peak of sedation or intermediate sedation. The moments of greatest sedation (intermediate and peak) influence all the items on the scale since their
vectors are directed to these ellipses. Each isolated symbol represents each assessment of each horse at each moment.
TABLE 7 | Spearman’s item-total correlation, internal consistency, sensitivity, and specificity of EquiSed.
EquiSed items Item-total correlation Internal consistency Sensitivity (CI) Specificity (CI)
All items Excluding each item below 0.73 0.96 (0.93–0.99) 0.83 (0.76–0.89)
Touch the ears 0.50 0.68 93 (91–96) 16 (12–20)
Pressure on the thoracic limb 0.49 0.69 42 (38–48) 74 (69–80)
Pressure on the pelvic limb 0.54 0.68 39 (34–44) 91 (88–94)
Postural instability 0.50 0.68 78 (74–82) 62 (57–67)
Auditory stimulus 0.31 0.73 100 (100–100) 1 (1–1)
Visual stimulus 0.49 0.68 100 (99–100) 8 (6–12)
EquiSed—Numerical composite sedation scale in horses. Interpretation of the Spearman item-total correlation (rs)—values between 0.3 and 0.7 are acceptable and are in bold (33).
Interpretation of Cronbach’s α coefficient (internal consistency): minimally acceptable 0.60–0.64, acceptable 0.65–0.69, good 0.70–0.74, very good 0.75–0.80, and excellent > 0.80
(38). Acceptable values are in bold. Interpretation for sensitivity and specificity: excellent 95–100%, good 85–94.9%, moderate 70–84.9%, and not sensitive or specific< 70% (24, 39).CI:
confidence interval. Values with acceptable sensitivity and specificity are in bold (> 70%).
With respect to specificity, only the items pressure on the
limbs were specific. The lack of specificity of some items is
associated with a limitation of the study, where docile horses may
not respond to stimulus leading to scores above zero at baseline.
It is probable that horses under stress or agitation, and in an
unfamiliar environment, unlike our study, would have lowered
the scores on all items before sedation as they would respond
more readily to stimuli.
The high sensitivity and specificity of the total score of
EquiSed compensated for below the expected results of sensitivity
and specificity of the isolated items. The HHAG% was used as
a predictive value for this calculation because it is an objective
and consecrated method to assess sedation (2, 5, 7, 11, 12).
Total EquiSed scores>7 (YI) indicates that horses are sufficiently
sedated for clinical and or surgical procedures, and this is
information may be useful for clinical use.
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FIGURE 3 | Histogram of eigenvalues of each dimension of the principal component analysis. First dimensions represent the majority of the items of Equised with
eigenvalues > 1.0.
FIGURE 4 | Area under the curve (AUC) and two-graph ROC curve with the diagnostic uncertainty zone for the EquiSed. Receiver operating characteristic (ROC)
curve with a 95% confidence interval (CI) calculated from 1,001 replications and under the curve (AUC). Interpretation of AUC: low (0.5–0.7), moderate (0.7–0.9), and
high (> 0.9) discriminatory capacity (41). Two-graph ROC curve, CI of 1,001 replications, and sensitivity and specificity >0.90 applied to estimate the diagnostic
uncertainty zone of the cut-off point according to the Youden index for the EquiSed. The diagnostic uncertainty zone ranged from 7 to 10; scores < 7 are horses that
are not sufficiently sedated while scores > 10 are those that are truly sedated. Youden index > 7 represents the cut-off point for sufficient sedation.
Although the EquiSed was validated in its entirety with all
included items, since the reliability and validity analyses were
carried out separately for each item, when, in an experimental
or clinical situation, one of the stimuli cannot be used (for
example the auditory or visual, as they can frighten animals),
they could be excluded, and the scale adapted. However, it is
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FIGURE 5 | Frequency distribution of EquiSed scores before and after tranquilization (ACP—Treatments ACPL+ACPH), low detomidine (LD—Treatments DL+DLM),
and high detomidine (HD—Treatments DH+DHM). ACPL and ACPH—Acepromazine in low and high doses, respectively, DL and DLM—Detomidine in low dose and
associated with methadone, respectively, DH and DHM—Detomidine in high dose and associated with methadone, respectively. Baseline—basal sedation, Peak of
sedation—peak sedation, Intermediate—intermediate sedation, and End of sedation.
emphasized that a new validation of the adapted scale would
be necessary.
Our study is not free of limitations. The first limitation was the
docile temperament and previous adaptation of the horses to the
environment, personnel, and handling, which possibly explain
the lack of specificity of some EquiSed stimuli. To address this
deficiency, the scale should be tested in animals with different
temperaments to confirm or not this assumption. A second
limitation was that the performance of the unidimensional scales
might have been inflated by the experience of the evaluators
and by prior knowledge of the behavioral indicators of sedation
described in the EquiSed. This method of assessment possibly
contributed to the very similar responsiveness results among the
unidimensional scales and EquiSed. A third limitation is the
limited number of horses, however based on the 4 R’s (reduce,
replace, refine, and respect), the number of horses were reduced
to the minimum necessary, but still based on the sample size
calculated. The fourth limitation was the lack of independence
for observations represented by the replicated use of seven horses
submitted to six treatments, evaluated by four observers in 4
moments of two phases, with a total of 168 evaluations. This
limitation may lead to an inflated alpha of the hypothesis tests
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and for the confidence intervals. A final limitation was that 16
videos used for training were selected from the 168 videos used in
the main study. Therefore, evaluators could be able to recognize
each single horse when assessing themain study videos. However,
we do not believe this was a bias because in both cases evaluators
were unaware of the moment at which the videos were recorded,
and the horses were very similar in appearance.
To summarize, the main advantage of EquiSed over HHAG is
the ability to differentiate tranquilization from baseline (without
the effect of CNS depressors) and the low level of tranquilization
from high level of tranquilization and from low sedation. Besides
that, EquiSed, but not HHAG%, was able to differentiate low
from high sedation state. The disadvantage of EquiSed is the
need for interaction with the horse, especially in clinical practice,
contrasting other scales based on facial expression, for example.
Otherwise, one of the disadvantages of HHAG is that it cannot be
used in dental practice.
EquiSed presents intra- and interobserver reliability and
content, criterion, and construct validity in horses tranquilized
with acepromazine or sedated with detomidine alone or
associated with methadone. EquiSed is easily applicable and
differentiates low from high sedation and low from high
tranquilization. However, considering that the data replication
originated from the grouping of horses, observers and moments
may have inflated the alpha values facilitating type I error in
results, future experimental and/or clinical studies may either
confirm or not the usefulness, reproducibility and validity of
the scale.
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